Cargando…
A Potential of an Anti-HTLV-I gp46 Neutralizing Monoclonal Antibody (LAT-27) for Passive Immunization against Both Horizontal and Mother-to-Child Vertical Infection with Human T Cell Leukemia Virus Type-I
Although the number of human T-cell leukemia virus type-I (HTLV-I)-infected individuals in the world has been estimated at over 10 million, no prophylaxis vaccines against HTLV-I infection are available. In this study, we took a new approach for establishing the basis of protective vaccines against...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4776196/ https://www.ncbi.nlm.nih.gov/pubmed/26848684 http://dx.doi.org/10.3390/v8020041 |
_version_ | 1782419111404371968 |
---|---|
author | Fujii, Hideki Shimizu, Mamoru Miyagi, Takuya Kunihiro, Marie Tanaka, Reiko Takahashi, Yoshiaki Tanaka, Yuetsu |
author_facet | Fujii, Hideki Shimizu, Mamoru Miyagi, Takuya Kunihiro, Marie Tanaka, Reiko Takahashi, Yoshiaki Tanaka, Yuetsu |
author_sort | Fujii, Hideki |
collection | PubMed |
description | Although the number of human T-cell leukemia virus type-I (HTLV-I)-infected individuals in the world has been estimated at over 10 million, no prophylaxis vaccines against HTLV-I infection are available. In this study, we took a new approach for establishing the basis of protective vaccines against HTLV-I. We show here the potential of a passively administered HTLV-I neutralizing monoclonal antibody of rat origin (LAT-27) that recognizes epitopes consisting of the HTLV-I gp46 amino acids 191–196. LAT-27 completely blocked HTLV-I infection in vitro at a minimum concentration of 5 μg/mL. Neonatal rats born to mother rats pre-infused with LAT-27 were shown to have acquired a large quantity of LAT-27, and these newborns showed complete resistance against intraperitoneal infection with HTLV-I. On the other hand, when humanized immunodeficient mice were pre-infused intravenously with humanized LAT-27 (hu-LAT-27), all the mice completely resisted HTLV-I infection. These results indicate that hu-LAT-27 may have a potential for passive immunization against both horizontal and mother-to-child vertical infection with HTLV-I. |
format | Online Article Text |
id | pubmed-4776196 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-47761962016-03-09 A Potential of an Anti-HTLV-I gp46 Neutralizing Monoclonal Antibody (LAT-27) for Passive Immunization against Both Horizontal and Mother-to-Child Vertical Infection with Human T Cell Leukemia Virus Type-I Fujii, Hideki Shimizu, Mamoru Miyagi, Takuya Kunihiro, Marie Tanaka, Reiko Takahashi, Yoshiaki Tanaka, Yuetsu Viruses Article Although the number of human T-cell leukemia virus type-I (HTLV-I)-infected individuals in the world has been estimated at over 10 million, no prophylaxis vaccines against HTLV-I infection are available. In this study, we took a new approach for establishing the basis of protective vaccines against HTLV-I. We show here the potential of a passively administered HTLV-I neutralizing monoclonal antibody of rat origin (LAT-27) that recognizes epitopes consisting of the HTLV-I gp46 amino acids 191–196. LAT-27 completely blocked HTLV-I infection in vitro at a minimum concentration of 5 μg/mL. Neonatal rats born to mother rats pre-infused with LAT-27 were shown to have acquired a large quantity of LAT-27, and these newborns showed complete resistance against intraperitoneal infection with HTLV-I. On the other hand, when humanized immunodeficient mice were pre-infused intravenously with humanized LAT-27 (hu-LAT-27), all the mice completely resisted HTLV-I infection. These results indicate that hu-LAT-27 may have a potential for passive immunization against both horizontal and mother-to-child vertical infection with HTLV-I. MDPI 2016-02-03 /pmc/articles/PMC4776196/ /pubmed/26848684 http://dx.doi.org/10.3390/v8020041 Text en © 2016 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons by Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Fujii, Hideki Shimizu, Mamoru Miyagi, Takuya Kunihiro, Marie Tanaka, Reiko Takahashi, Yoshiaki Tanaka, Yuetsu A Potential of an Anti-HTLV-I gp46 Neutralizing Monoclonal Antibody (LAT-27) for Passive Immunization against Both Horizontal and Mother-to-Child Vertical Infection with Human T Cell Leukemia Virus Type-I |
title | A Potential of an Anti-HTLV-I gp46 Neutralizing Monoclonal Antibody (LAT-27) for Passive Immunization against Both Horizontal and Mother-to-Child Vertical Infection with Human T Cell Leukemia Virus Type-I |
title_full | A Potential of an Anti-HTLV-I gp46 Neutralizing Monoclonal Antibody (LAT-27) for Passive Immunization against Both Horizontal and Mother-to-Child Vertical Infection with Human T Cell Leukemia Virus Type-I |
title_fullStr | A Potential of an Anti-HTLV-I gp46 Neutralizing Monoclonal Antibody (LAT-27) for Passive Immunization against Both Horizontal and Mother-to-Child Vertical Infection with Human T Cell Leukemia Virus Type-I |
title_full_unstemmed | A Potential of an Anti-HTLV-I gp46 Neutralizing Monoclonal Antibody (LAT-27) for Passive Immunization against Both Horizontal and Mother-to-Child Vertical Infection with Human T Cell Leukemia Virus Type-I |
title_short | A Potential of an Anti-HTLV-I gp46 Neutralizing Monoclonal Antibody (LAT-27) for Passive Immunization against Both Horizontal and Mother-to-Child Vertical Infection with Human T Cell Leukemia Virus Type-I |
title_sort | potential of an anti-htlv-i gp46 neutralizing monoclonal antibody (lat-27) for passive immunization against both horizontal and mother-to-child vertical infection with human t cell leukemia virus type-i |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4776196/ https://www.ncbi.nlm.nih.gov/pubmed/26848684 http://dx.doi.org/10.3390/v8020041 |
work_keys_str_mv | AT fujiihideki apotentialofanantihtlvigp46neutralizingmonoclonalantibodylat27forpassiveimmunizationagainstbothhorizontalandmothertochildverticalinfectionwithhumantcellleukemiavirustypei AT shimizumamoru apotentialofanantihtlvigp46neutralizingmonoclonalantibodylat27forpassiveimmunizationagainstbothhorizontalandmothertochildverticalinfectionwithhumantcellleukemiavirustypei AT miyagitakuya apotentialofanantihtlvigp46neutralizingmonoclonalantibodylat27forpassiveimmunizationagainstbothhorizontalandmothertochildverticalinfectionwithhumantcellleukemiavirustypei AT kunihiromarie apotentialofanantihtlvigp46neutralizingmonoclonalantibodylat27forpassiveimmunizationagainstbothhorizontalandmothertochildverticalinfectionwithhumantcellleukemiavirustypei AT tanakareiko apotentialofanantihtlvigp46neutralizingmonoclonalantibodylat27forpassiveimmunizationagainstbothhorizontalandmothertochildverticalinfectionwithhumantcellleukemiavirustypei AT takahashiyoshiaki apotentialofanantihtlvigp46neutralizingmonoclonalantibodylat27forpassiveimmunizationagainstbothhorizontalandmothertochildverticalinfectionwithhumantcellleukemiavirustypei AT tanakayuetsu apotentialofanantihtlvigp46neutralizingmonoclonalantibodylat27forpassiveimmunizationagainstbothhorizontalandmothertochildverticalinfectionwithhumantcellleukemiavirustypei AT fujiihideki potentialofanantihtlvigp46neutralizingmonoclonalantibodylat27forpassiveimmunizationagainstbothhorizontalandmothertochildverticalinfectionwithhumantcellleukemiavirustypei AT shimizumamoru potentialofanantihtlvigp46neutralizingmonoclonalantibodylat27forpassiveimmunizationagainstbothhorizontalandmothertochildverticalinfectionwithhumantcellleukemiavirustypei AT miyagitakuya potentialofanantihtlvigp46neutralizingmonoclonalantibodylat27forpassiveimmunizationagainstbothhorizontalandmothertochildverticalinfectionwithhumantcellleukemiavirustypei AT kunihiromarie potentialofanantihtlvigp46neutralizingmonoclonalantibodylat27forpassiveimmunizationagainstbothhorizontalandmothertochildverticalinfectionwithhumantcellleukemiavirustypei AT tanakareiko potentialofanantihtlvigp46neutralizingmonoclonalantibodylat27forpassiveimmunizationagainstbothhorizontalandmothertochildverticalinfectionwithhumantcellleukemiavirustypei AT takahashiyoshiaki potentialofanantihtlvigp46neutralizingmonoclonalantibodylat27forpassiveimmunizationagainstbothhorizontalandmothertochildverticalinfectionwithhumantcellleukemiavirustypei AT tanakayuetsu potentialofanantihtlvigp46neutralizingmonoclonalantibodylat27forpassiveimmunizationagainstbothhorizontalandmothertochildverticalinfectionwithhumantcellleukemiavirustypei |